News vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
24.98 ^USD	+1.13%		-10.47%	+117.22%

Mar. 14	VTv Therapeutics Inc. Announces Board Changes	CI
Mar. 13	VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VTv Therapeutics : 2024 Notice of Annual Meeting and Proxy Statement	Apr. 29	PU
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT	Mar. 19	PR
VTv Therapeutics Inc. Announces Board Changes	Mar. 14	CI
VTv Therapeutics: Q4 Earnings Snapshot	Mar. 13	AQ
VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update	Mar. 13	AQ
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	Mar. 04	AQ
VTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	Mar. 04	AQ
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	Mar. 04	CI
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	Mar. 01	AQ
Top Midday Gainers	Feb. 28	MT
VTv Therapeutics Inc. Announces Board Changes	Feb. 28	CI
VTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund	Feb. 28	AQ
VTv Therapeutics Inc. announced that it has received $50.961457 million in funding from JDRF T1D Fund, Samsara BioCapital LLC and another investors	Feb. 26	CI
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE	Feb. 22	PR
Vtv Therapeutics Inc. Announces Resignation of Chandresh Harjivan as Member of the Board of Directors	Dec. 22	CI
VTv Therapeutics: Q3 Earnings Snapshot	Nov. 09	AQ
VTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update	Nov. 09	AQ
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Summary

Filters